India HbA1c Testing Device Market - 2025-2033

The India HbA1c testing device market reached US$ 48.79 million in 2024 and is expected to reach US$ 96.80 million by 2033, growing at a CAGR of 7.97% during the forecast period 2025-2033.

HbA1c is a blood test that is used to diagnose type 2 diabetes. It is also used to monitor blood glucose control in people with diabetes. HbA1c is short for glycated hemoglobin. The test is also sometimes called hemoglobin A1c. The HbA1c test may also be done if we have symptoms of type 2 diabetes, to confirm a diagnosis.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Diabetes

The rising prevalence of diabetes in India is expected to drive the market over the forecast period. As the diabetes prevalence increases, there is an increasing demand for HbA1c testing. The hemoglobin A1c test measures the percentage of hemoglobin A in the blood that has glucose attached. For instance, according to the International Diabetes Federation, In India, there are an estimated 74,194.7 million people between the age of 20-79 years suffering from diabetes. The number of diabetes number is expected to increase to 124,874.7 by 2045. Adults with diabetes have a two- to three-fold increased risk of heart attacks and strokes.

High cost associated with HbA1c testing

The high cost associated with HbA1c testing is expected to hamper the market over the forecast period. For instance, Arkray PocketChem A1c HbA1c Test Kit may come at a price of a whopping 20,000 rupees This may limit the use of HbA1c devices in the country. Likewise, several manufacturers have high-end prices for HbA1c test kits, analyzers, and POCT devices which are not affordable by many middle-income families or a small diagnostic center with less investment.

Segment Analysis

The India HbA1c testing device market is segmented based on type, technology, modality, and end-user.

Technology:

HPLC based segment is expected to dominate the India HbA1c testing device market share

The HPLC-based segment is expected to hold a significant position in the India HbA1c testing device market. High-Performance Liquid Chromatography, or HPLC, is the gold standard method for hemoglobin A1c testing. HbA1c testing uses various technologies like immunoassay, HPLC, nephelometry, turbidometry, and enzymatic assay. Ion-exchange HPLC is the most widely used technology, considered the gold standard for HbA1c quantification due to its high sensitivity and specificity. Most market leaders offer HbA1c testing products based on the HPLC technique, making it indispensable for HbA1c detection.

For instance, Bio-Rad Laboratories, Inc. a major player in the market offers the HbA1c testing platform "Ion-Exchange HPLC System: D-100" which is based on HPLC technology. Another major player in the market ARKRAY, Inc. has an HbA1c portfolio based on HPLC technology, Likewise, Trivitron Healthcare an Indian based company offers an HbA1c portfolio based on HPLC technology. HbA1c tests performed in laboratory settings majorly use HPLC technology.

On October 15, 2023, an article published in the National Center for Biotechnology Information stated that HPLC is the most widely used technique for HbA1c quantification due to its resilience and specificity.

Competitive Landscape

The major players in the India HbA1c testing device market include F. Hoffmann-La Roche Ltd, ARKRAY, Inc., Siemens Healthineers AG, Accurex Biomedical Pvt. Ltd., EKF Diagnostics Holdings PLC, Lifotronic Technology Co., Ltd., Abbott, HemoCue, i-SENS, Inc., Trivitron Healthcare and Bio-Rad Laboratories, Inc among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The India HbA1c testing device market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.